INTRODUCTION
The recently unveiled Paris System for Reporting Urinary Cytology (TPS) establishes a standardized diagnostic criteria and reporting system for urinary tract cytology specimens that focuses primarily on the detection of highgrade urothelial carcinoma (HGUC). 1 One goal of TPS is to reduce the number of indeterminate diagnoses and to apply indeterminate categories only to specimens associated with an increased risk of HGUC. The categories of atypical urothelial cells (AUC) and suspicious for HGUC are indeterminate categories associated with a lower and higher risk of HGUC, respectively. Whereas other morphological criteria distinguish these 2 categories, both require an elevated nuclear-to-cytoplasmic (N:C) ratio of 0.5; thus, under most circumstances, urothelial cells with N:C ratios <0.5 should be considered as benign. 1 This criterion is based primarily on the experts' experience and to the best of our knowledge has not been quantitatively validated in terms of predicting HGUC. 2, 3 Applying digital imaging and computerized analysis, we investigated the predictive value of N:C ratio cutoff values in indeterminate urinary tract cytology specimens.
MATERIALS AND METHODS
The current study was approved by the Johns Hopkins Institutional Review Board. We retrospectively retrieved voided urine specimens with the diagnosis of "atypical urothelial cells of uncertain significance" from the cytopathology archives at the Johns Hopkins Hospital between January 2010 and June 2012. During this period, the Johns Hopkins Hospital template for urologic cytology samples 4, 5 was applied and TPS terminology and criteria, including the N:C cutoff value, were not yet used in routine practice. Clinical information (including patient age, sex, and race) and follow-up cytological or pathological results were recorded. AUC specimens with HGUC on follow-up (AUC-HGUC) were defined as voided urine specimens with biopsy-proven HGUC or carcinoma in situ detected within 6 months. A control cohort of AUC specimens without HGUC on follow-up (AUC-N-HGUC) was defined as voided urine specimens having at least a 3-year history of negative follow-up, with at least 1 negative cytology or tissue biopsy specimen. Patients with biopsy-proven, low-grade urothelial neoplasia (LGUN) diagnosed within 6 months of follow-up also were classified as having AUC-N-HGUC. Exclusion criteria included: 1) inadequate or less than optimal specimens; 2) cases in which atypia was strictly due to urothelial tissue fragments and not identified in single cells; and 3) cases in which atypia was likely to be secondary to the cytopathic effect of polyomavirus. 6, 7 Voided urine specimens were prepared using the SurePath liquid-based cytology method (Becton, Dickinson and Company, Franklin Lakes, NJ). All cases initially were screened by a cytotechnologist. For each case, the number of atypical cells was recorded and microscopic images of single atypical cells or loosely cohesive atypical cell clusters were digitally photographed. Atypical cells were defined as nondegenerated, nonsuperficial urothelial cells with an increased N:C ratio and/or enlarged nuclei with hyperchromasia, irregular chromatin, and/or irregular nuclear membranes that were insufficient for a diagnosis of HGUC. The nuclear size and N:C ratio were evaluated using Adobe Illustrator CC (Adobe Systems Incorporated, San Jose, Calif) as previously described. 8 
Statistical Analysis
Data were summarized using descriptive statistics (count/ frequency for categorical variables and mean/range for continuous variables). Fisher exact tests were used to compare the distributions of categorical variables between the AUC-HGUC and AUC-N-HGUC cohorts; Student t tests and Wilcoxon rank sum tests were used to test for differences between the mean and median values of continuous variables in the 2 cohorts. Two-sided P values <.05 were considered to be statistically significant. We generated receiver operating characteristic (ROC) curves for classifying HGUC on follow-up based on the following variables: 1) the maximum N:C ratio among atypical cells; 2) the maximum nuclear size among atypical cells; and 3) the number of atypical cells found in a specimen. For each predictor variable, the optimal threshold for the classification of HGUC on follow-up was calculated as the threshold achieving the highest combination of sensitivity and specificity. We also sought to determine whether some combination of variables might provide better discriminatory power than any one variable alone. Information from multiple variables (the 3 variables mentioned above as well as the age and sex of each patient) was combined into a scalar score using multivariate logistic regression models. We considered selected combinations of the 5 variables based on the univariate discriminatory capacity of each, and computed ROC curves and the area under the curve for each model. Statistical analyses were performed using R statistical software (version 3.2.2; R Foundation for Statistical Computing, Vienna, Austria) with the pROC package. 9 
RESULTS

Patient and Specimen Characteristics
A total of 15 AUC-HGUC specimens and 33 AUC-N-HGUC specimens, comprised of 30 cases with benign follow-up for 3 years and 3 cases with LGUN detected on follow-up, met the inclusion criteria for the current study. The demographics and cytomorphologic parameters of the 2 groups are summarized in Table 1 . There were no significant differences noted with regard to age, sex, and race between patients in the AUC-HGUC and AUC-N-HGUC cohorts. A total of 412 atypical cells were digitally photographed and evaluated for their N:C ratio and nuclear size (Figs. 1-3 ).
The N:C Ratio Is Predictive of HGUC On average, the maximum N:C ratios among atypical cells were found to be significantly different between the AUC-HGUC and AUC-N-HGUC groups (0.53 vs 0.43; P 5.00009), whereas the maximum nuclear sizes (153.43 lM 2 vs 201.47 lM 2 ; P 5 .69) and the number of atypical cells (10.13 vs 7.88; P 5 .12) were not.
ROC analysis revealed that the maximum N:C ratio had a higher discriminatory capacity for predicting HGUC on follow-up (area under the curve, 79.19%; 95% confidence interval, 64.19%-94.19%) than the number of atypical cells and the maximum nuclear size among atypical cells, each of which performed no better than random classification (95% confidence intervals for the areas under the curves overlap, 50%) (Fig. 4) . The optimal maximum N:C ratio threshold was estimated to be 0.486, giving a sensitivity of 73.3% and a specificity of 86.7% for predicting follow-up HGUC.
Multivariate logistic regression models indicated that incorporating information regarding the maximum nuclear size, the number of atypical cells, and the age and sex of a patient did not improve the prediction of HGUC on follow-up by using the maximum N:C ratio alone (Table 2) .
Small Changes in the N:C Ratio Substantially Alter Sensitivity and Specificity
It is important to note that in the current study, small changes in the maximum N:C ratio threshold between 0.4 to 0.6 were found to correspond to substantial changes in resulting sensitivities and specificities (Fig. 5 ).
DISCUSSION
Indeterminate ("atypical") diagnoses within cytopathology often are criticized for their lack of specificity and reproducibility. There are many reasons why indeterminate diagnoses for urinary tract specimens are common in many cytopathology laboratories. First, the morphology of urothelial cells frequently is not well preserved due to shed urothelial cells being stored in the bladder for hours until a urine specimen is voided. Exposure to the urine fluid and human body temperatures likely contributes to cellular degeneration. Second, the absence of clearly defined and clinically relevant diagnostic criteria for urinary tract cytology specimens in the past has resulted in a low predictive value and high interobserver variability for indeterminate categories. Furthermore, the low predictive value of urinary tract cytology for LGUN interferes with the performance of indeterminate categories if they are used as an attempt to detect possible LGUN lesions.
Different diagnostic criteria for indeterminate ("atypical") urinary tract specimens have been proposed. 2, 3, [10] [11] [12] [13] [14] [15] [16] In a review article, Murphy recommended that no cell with an N:C ratio 1:2 should be considered as malignant. 2 Following this concept, Brimo et al considered an N:C ratio of >0.5 to be a quantitative criterion with which to distinguish urothelial cells that should be diagnosed as atypical. 3 TPS adopted this N:C ratio as a required criterion for the diagnosis of AUC; however, this cutoff value is based on the experience of experts and to our knowledge has not been validated quantitatively.
In the current study, we demonstrated that the mean of the maximum N:C ratios found in urinary tract specimens were significantly different between the AUC-HGUC and AUC-N-HGUC cohorts. This result supports the idea that the N:C ratio is a useful criterion with which to assess a patient's risk of HGUC. Furthermore, we calculated the optimal N:C ratio cutoff value; the threshold of 0.486 was found to have a sensitivity of 73.3% and a specificity of 86.7% for predicting HGUC.
The N:C ratio of the same cell could significantly vary with different cytopreparation methods. 17, 18 Cells in cytospin preparations usually have a lower N:C ratio (fixation after placing cells on the slide, similar to a fried egg) compared with liquid-based preparations (fixation before placing cells on the slide, similar to a bisected boiled egg). Therefore, individual laboratories using different cytopreparation methods may need to validate the N:C ratio cutoff value independently.
It is important to note that data from the current study demonstrate that small changes in the N:C ratio threshold between 0.4 and 0.6 may substantially alter the sensitivity and specificity of predicting HGUC on followup. This finding underscores the difficulty of determining such small changes in the N:C ratios when estimated by the human eye with light microscopy alone. Previous studies have shown that morphologists tended to overestimate the N:C ratio of urothelial cells, especially at N:C ratios close to cutoff values in TPS. 8, 19, 20 The current study data suggest that overestimating the N:C ratio would result in a slightly increased sensitivity but a markedly decreased specificity for HGUC. These data support the possible integration of automated digital imaging and/or computerized measurement of N:C ratios in urinary tract specimens, because the added precision could have a significant impact. Indeed, a major limitation of the current study is that the manual methods used are very time-consuming and are not practical for integration into daily clinical signout. This also limits the number of samples that could be practically included in the current study. The development of automated digital imaging techniques could allow for larger studies to examine the role of the N:C ratio in predicting HGUC on follow-up, and quantify more carefully how minor variations in the N:C ratio threshold may alter the sensitivities and specificities of the classifying HGUC. We also examined other parameters that have been proposed but not adopted by TPS for stratifying AUC, including the number of atypical cells and nuclear Abbreviations: 95% CI, 95% confidence interval; AUC, area under the curve; N:C, nuclear-to-cytoplasmic. Figure 5 . The sensitivity (in black) and specificity (in blue) of predicting high-grade urothelial carcinoma (HGUC) on follow-up for each chosen nuclear-to-cytoplasmic (N:C) ratio threshold (x-axis).
The optimal threshold, which provides the highest combination of sensitivity and specificity in the study sample, is plotted as a vertical dashed gray line at an N:C threshold of 0.486. Note that small changes in the N:C ratio threshold between 0.4 and 0.6 are associated with substantial differences in the sensitivities and specificities of predicting HGUC on follow-up.
enlargement. 15, 21, 22 The current analysis did not find these 2 parameters to have diagnostic value in indeterminate specimens; however, this result may be limited by the power of the study and does not necessarily apply to other diagnostic categories.
McCroskey et al reported that indeterminate urinary tract specimens with benign follow-up had a lower average number of atypical cells per slide compared with specimens with a malignant follow-up. 23 We found that models combining information regarding maximum N:C ratios with the number of atypical cells did not perform significantly better than those in which classification was based on the maximum N:C ratios alone. Brimo et al reported that >10 atypical cells in urinary tract specimens correlated with a significantly higher rate of subsequent HGUC. 22 However, in their study cohort, they included specimens that not only were diagnosed as "atypical," but also as "suspicious" and "positive for HGUC." The number of AUC in the AUC of uncertain significance specimens at the study institution usually is less than that found in specimens that are suspicious or positive for HGUC, and this may explain why we did not find a statistical association. Kern reported a gradual increase in nuclear size when considering the spectrum of benign, reactive, low-grade, and high-grade lesions. 21 However, we did not find that the maximum nuclear size of atypical cells correlated to the follow-up HGUC results in the current study; therefore, it did not support using enlarged nuclei alone as a diagnostic criterion for AUC. The identification of AUC with an N:C ratio >0.486 has a high predictive power for HGUC on follow-up. This may be limited to voided urine specimens prepared using the SurePath liquid-based method, and may not apply to other preparations or instrumented specimens. This supports the use of 0.5 as a cutoff value for the AUC category of TPS. However, given that small changes in the N:C ratio cutoff value appear to result in dramatic changes in sensitivity and specificity, the use of digital image analysis may improve the precision of diagnosis in urinary tract specimens.
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